If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
84.80    2.70 (3.29%)
Bid:
84.20
Ask:
84.70
Spread: 0.50 (0.594%)
Market Cap: £240.37m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Director/PDMR Shareholding

4 Apr 2023 08:49

RNS Number : 3020V
Essentra plc
04 April 2023
 

Essentra plc (the "Company")

Director/PDMR Holding

The notification below, is made on behalf of PDMRs under article 19.1 of the Market Abuse Regulation ('MAR') and in accordance with Article 19.3 of MAR.

On 31 March 2023, the Company made grants of performance shares under the Long-Term Incentive Plan to Group Executive Committee members who are PDMRs of Essentra plc.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Sam Edwards

Gabriele Hannen

Hugues Delcourt

Robert Baker

Lynne Vandeveer

Emma Reid

 

2

 

Reason for the notification

 

a)

Position/status

 

Sam Edwards Chief Digital Information Officer

Gabriele Hannen Chief Strategy Officer

Hugues Delcourt Chief Sales Officer and Director, EMEARobert Baker Chief Operating Officer

Lynne Vandeveer Chief Marketing Officer and President, AmericasEmma Reid Company Secretary

 

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Essentra plc

b)

 

LEI

 

5493007MOZNA03BVNE96

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 25p shares

Identification code

GB00B0744359

b)

 

Nature of the transaction

 

 

Award of performance shares under the Essentra plc Long-Term Incentive Plan Part B. The shares are deferred for three years subject to the attainment of performance conditions.

 

c)

Price(s) and volume(s)

Name

Price (£)

Volume

Sam Edwards

1.9580

71,629

Gabriele Hannen

1.9580

97,077

Hugues Delcourt

1.9580

93,025

Robert Baker

1.9580

75,970

Lynne Vandeveer

1.9580

116,602

Emma Reid

1.9580

65,1177

d)

Aggregated information

- Aggregrated volume

 

- Price

 

518,420

 

£1.9580

 

e)

 

Date of the transaction

 

31 March 2023

f)

 

Place of the transaction

London Stock Exchange

 

 

For further enquiries, please contact:

Essentra plc

Emma Reid, Company Secretary

Tel: +44 (0)1908 359100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUBCCUPWUMC
Date   Source Headline
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20263:23 pmRNSHolding(s) in Company
5th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares - Replacement
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSFY2025 Pre-close Trading Update
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20268:19 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSAcquisition of Device Technologies
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:26 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.